Colombia Starts Cannabis Health Insurance – LA Week

The health insurance that is funded by the state of Colombia includes the drug cannabis.

Those who have been working in the country for a long time are sure to be happy as they prepare to meet the high demands. Wise Tree one of the best ways to take advantage of that growing interest. Clever Leaves was founded in 2016 by Andres Fajardo, a longtime business partner, and The Former Drug Policy director of Colombia. Think more about someone who ran the Office of National Drug Policy that falls under the special branch as opposed to the head of the Drug Enforcement Administration (DEA).

“We saw an opportunity because the law was quickly changed and we think that Colombia has what it takes to win the global cannabis market, due to its price and agricultural conditions,” Fajardo told LA Weekly from Colombia.

Andrew Fajardo

Fajardo and his colleagues were also happy to create a way to help with the regulations that will come down the pipeline and participate in an important step for the history of cannabis in the country.

Although things are happening quickly, much of that history has long been embedded in the series of land-races that reached the coast of Santa Marta about 1,000 kilometers north of the capital Bogota. The most famous was Colombian Gold which lived up to its name because when the hoards reached the other side of the Caribbean, someone was getting rich.

Although the change in the law at the end of the 2010s is certainly something, the main policy that allowed medical cannabis in Colombia is a law from 1986.

“The law was passed but the order and major parts of the law were not there. But they passed some, some of them at the end of 2015,” explained Fajardo. “The opportunity was opened, we got a license, but during 2016 and 2017, there was a change in the regulations.”

That change is the breathing room they need to start building a real business in Colombia. By January of 2018, they have received more money from the US and are very nervous. It now covers 1.8 million square meters of land.

When they first got the ball rolling, they were allowed to make comments. But everything has changed.

Fajardo said that most of the cannabis that is grown in Colombia right now is intended for marijuana flowers. Of course, things are still being developed for installation, they have been selling it abroad for a few years. Now it’s about the preparation of the next big product to be exported, lobster flowers. Everything Lauau Atamai needs to export flowers has been legalized for the past two years; Exports are expected to begin in the first quarter of 2023.

The biggest markets for Clever Leaves are expected to be Germany and Australia.

According to Fajardo, many of the company’s pains occurred in their Portuguese home in the past. There they learned important lessons about how to grow shrimp plants in comparison to the high biomass, but not the terp-heavy type that they are. refrigerated in California.

Another thing they like, is that they will be able to grow a lot of different cannabis on their cheap garden in the hope of finding something that speaks to everyone.

“The cost of Colombian energy that we have allows us to launch more and more interventions more easily than other countries,” said Fajardo. “So we hope to expand our flower production in 2023 and the years after.”

Fajardo said Colombia’s natural light cycle and climate will play a big role in that. The days are about 12 hours of sunshine and darkness each year, so they have to adjust for the cold and wet seasons, which have long been common in Colombian agriculture.

Fajardo explained what people from Colombia were going through a few years ago, before the federal insurance. He believes that the opportunity is very difficult for patients, especially in a country like Colombia, with public health. The improvement of the industry has now allowed the industry to evolve to meet the needs.

But what makes being a medical cannabis company in a public health environment difficult?

“Colombians are not used to spending money because everything is paid for.” So if you say you pay $6, that’s fine. But if you ask them to pay 20, 30, 40 dollars, people will not do it,” said Fajardo. “So the question is, will the drug be available and affordable? So with this change, the expansion of the market has increased because there are 50 million people, all of us are insured. This provides a very interesting opportunity. “

We should have an idea in the next few months of the level of demand they expect in the Colombian medical market.

Advertising notice: We may receive compensation for some of the links in our articles. Thank you for supporting LA Weekly and our ads.

Leave a Comment